Category Archives: General HIV+ population

Reviews on HIV+ people where the population is not specified

Nucleoside reverse transcriptase inhibitors in combination therapy for HIV patients: Systematic review and meta-analysis

2010

Treatment guidelines recommend dual nucleoside reverse transcriptase inhibitors (NRTI ) as a part of combination antiretroviral therapy. The objective of this study was to assess the relative efficacy and toxicity...

Influenza vaccination for immunocompromised patients: Systematic review and meta-analysis from a public health policy perspective

2011

BACKGROUND: Immunocompromised patients are vulnerable to severe or complicated influenza infection. Vaccination is widely recommended for this group. This systematic review and meta-analysis assesses influenza vaccination for immunocompromised patients in...

Entry and retention in medical care among HIV-diagnosed persons: A meta-analysis

2010

OBJECTIVE: A ‘test and treat’ strategy to reduce HIV transmission hinges on linking and retaining HIV patients in care to achieve the full benefit of antiretroviral therapy. We integrated empirical...

HIV-related lipodystrophy in Africa and Asia

2009

No abstract.

Barriers to access to antiretroviral treatment in developing countries: A review

2008

OBJECTIVE: To present a review of barriers impeding people living with HIV/AIDS in developing countries from accessing treatment, and to make recommendations for further studies. METHODS: Electronic databases, websites of...

Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa

2008

Two-thirds of the world’s HIV-infected people live in sub-Saharan Africa, and more than 1.5 million of them die annually. As access to antiretroviral treatment has expanded within the region; early...

Peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virus

2009

OBJECTIVES: The aim of this study was to assess the effects of peginterferon plus ribavirin for chronic hepatitis C in patients with human immunodeficiency virus (HIV). METHODS: Trials were identified...

Rifabutin for treating pulmonary tuberculosis

2007

Background: Rifamycins are an essential component of modern short-course regimens for treating tuberculosis. Rifabutin has favourable pharmacokinetic and pharmacodynamic properties and is less prone to drugdrug interactions than rifampicin. It...

Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB

2013

Background: Preventing active tuberculosis (TB) from developing in people with latent tuberculosis infection (LTBI) is important for global TB control. Isoniazid (INH) for six to nine months has 60% to...

Efficacy and tolerability of initial antiretroviral therapy: A systematic review

2009

OBJECTIVES: Successful antiretroviral therapy (ART) is largely attributed to the type of third drug. Guidelines recommend regimens without systematic review of all factors that might affect treatment success, such as...

Corticosteroid administration and outcome of adolescents and adults with acute bacterial meningitis: A meta-analysis

2009

OBJECTIVE: To systematically assess the effect of the adjunctive administration of corticosteroids in the treatment of acute bacterial meningitis. METHODS: We performed a systematic review and meta-analysis by searching several...

Understanding HIV-related posttraumatic stress disorder in South Africa: A review and conceptual framework

2011

A number of epidemiological studies have attempted to measure the prevalence of HIV-related posttraumatic stress disorder (PTSD) in sub-Saharan Africa. A systematic review of the literature identified eight relevant studies...

Email 1 selected articles

Email 1 selected articles

Error! The email wasn't sent. Please try again.

Your email has been sent!